Tested Applications
| Positive WB detected in | HepG2 cells, human liver tissue |
| Positive IHC detected in | human liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
14990-1-AP targets RPL39 in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse, zebrafish |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag6975 Product name: Recombinant human RPL39 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-51 aa of BC001019 Sequence: MSSHKTFRIKRFLAKKQKQNRPIPQWIRMKTGNKIRYNSKRRHWRRTKLGL Predict reactive species |
| Full Name | ribosomal protein L39 |
| Calculated Molecular Weight | 6 kDa |
| Observed Molecular Weight | 6 kDa |
| GenBank Accession Number | BC001019 |
| Gene Symbol | RPL39 |
| Gene ID (NCBI) | 6170 |
| RRID | AB_2238670 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P62891 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for RPL39 antibody 14990-1-AP | Download protocol |
| IHC protocol for RPL39 antibody 14990-1-AP | Download protocol |
| WB protocol for RPL39 antibody 14990-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The RPL39 Polyclonal antibody (Cat# 14990-1-AP) has 9 citations published in journals including Cell Discov, Mol Cell, Front Immunol, Transl Res, Front Endocrinol, iScience, Int J Biochem Cell Biol, J Cancer Res Clin Oncol, and Elife. Research fields span ribosome biology, chromosome clustering, nascent polypeptide scanning, glioma prognosis and molecular subtyping, microvesicle communication in myeloma, spermatogenesis, proteostasis, cell proliferation, and zebrafish heart regeneration.
| Species | Application | Title |
|---|---|---|
Front Immunol Identification and validation of a 17-gene signature to improve the survival prediction of gliomas
| ||
Transl Res Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication. | ||
Front Endocrinol (Lausanne) An integrated transcriptomic analysis unveils the regulatory roles of RNA binding proteins during human spermatogenesis | ||
iScience Proteostasis regulated by testis-specific ribosomal protein RPL39L maintains mouse spermatogenesis.
|









